Search Results - "Keegan, DL"

Neuroleptic malignant syndrome: case report and discussion by Chandran, Geethan J, Mikler, John R, Keegan, David L

“…We report a case involving an 81-tear-old man with schizoaffective disorder who presented with neuroleptic malignant syndrome (NMS) after an increase in his…”
Get full text

Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor by Li, Xin-Min, Chlan-Fourney, Jennifer, Juorio, Augusto V., Bennett, Vern L., Shrikhande, Satish, Keegan, David L., Qi, Jin, Boulton, Alan A.

“…Neuroanatomical studies of schizophrenia suggest that progressive neuropathological changes (such as neuronal atrophy and/or cell death) occur over the…”
Get full text

Neuropsychopharmacology of Pathological Aggression and Sexuality by Keegan, D L

Get full text

A Survey of the Use of Community Treatment Orders by Psychiatrists in Saskatchewan by O'Reilly, RL, Keegan, DL, Elias, JW

“…Objective: To determine the pattern of use and satisfaction with community treatment orders (CTOs) by psychiatrists in Saskatchewan. Method: All psychiatrists…”
Get full text

Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic Therapy: A Retrospective Analysis Using the Saskatchewan Health Linkable Databases by Albright, Penny S., Livingstone, Scott, Keegan, David L., Ingham, Michael, Shrikhande, Satish, Le Lorier, Jacques

Get full text

Defining Treatment Refractoriness in Schizophrenia by Brenner, Hans D., Dencker, Sven J., Goldstein, Michael J., Hubbard, John W., Keegan, David L., Kruger, Gerd, Kulhanek, Franz, Liberman, Robert P., Malm, Ulf, Midha, Kamal K.

“…Addressing the need for research on the nature of refractoriness to antipsychotic drug therapy exhibited by a substantial minority of schizophrenic patients,…”
Get full text

Long-Term Healthcare Resource Utilisation and Costs Before and After Initiation of Risperidone Treatment in Patients with Chronic Schizophrenia by Keegan, David L., Albright, Penny, Petersen, Trish

Get full text

Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients by Miller, P S, Richardson, J S, Jyu, C A, Lemay, J S, Hiscock, M, Keegan, D L

“…Low-dose scopolamine, given as presurgery medication, resulted in low levels of serum anticholinergic activity and caused measurable cognitive impairment in 18…”
Get more information

Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline by Richardson, J S, Keegan, D L, Bowen, R C, Blackshaw, S L, Cebrian-Perez, S, Dayal, N, Saleh, S, Shrikhande, S

“…After 1 week of a single-blind placebo period, and prior to being randomly assigned to receive treatment with either fluoxetine or amitriptyline, patients…”
Get more information

A new mechanism for the actions of olanzapine by Li, X M, Juorio, A V, Chlan-Fourney, J, Shrikhande, S, Bennett, V L, Keegan, D L

Get full text

Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors by Ward, M M, Mefford, I N, Parker, S D, Chesney, M A, Taylor, C B, Keegan, D L, Barchas, J D

“…The present study employed continuous blood withdrawal to examine epinephrine and norepinephrine responses to a cognitive stressor (mental arithmetic), active…”
Get more information

Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection by Mefford, I N, Ward, M M, Miles, L, Taylor, B, Chesney, M A, Keegan, D L, Barchas, J D

Get more information

The noncompliance factor in the dexamethasone suppression test by Remillard, A J, O'Reilly, R, Gorecki, D K, Blackshaw, S L, Quinn, D, Keegan, D L

Get more information

Intersubject variation in the pharmacokinetics of haloperidol and reduced haloperidol by Midha, K K, Chakraborty, B S, Ganes, D A, Hawes, E M, Hubbard, J W, Keegan, D L, Korchinski, E D, McKay, G

“…Single oral doses (5 mg) of haloperidol were administered to 36 healthy men (26 black, 10 white) of whom 28 (22 black, 6 white) completed the study. Plasma…”
Get more information

Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depression by Davis, B A, Boulton, A A, Yu, P H, Durden, D A, Keegan, D L, Bowen, R C, Blackshaw, S, D'Arcy, C, Remillard, A J, Dayal, N

“…Unconjugated (U-PAA), conjugated (C-PAA), and total phenylacetic acid (T-PAA) concentrations in blood plasma and monoamine oxidase (MAO) activity in platelets…”
Get more information

Types of depression in alcoholic patients by Bowen, R. C, Cipywnyk, D, D'Arcy, C, Keegan, D. L

“…Standardized clinical interviews of 48 alcoholic patients consecutively admitted to an alcoholism treatment program revealed that 22 (46%) had suffered major…”
Get full text

The Doctor's and the Patient's Problems in Treating Obesity by Keegan, D L

“…The major difficulties for physicians and patients alike in the management of obesity are lack of goals, poor understanding of their roles in diet therapy and…”
Get full text

Mental dysfunction and the blockade of muscarinic receptors in the brains of the normal elderly by Richardson, J S, Miller, P S, Lemay, J S, Jyu, C A, Neil, S G, Kilduff, C J, Keegan, D L

“…Cholinergic neurons innervate many areas of the brain and the disruption of acetylcholine neurotransmission at the muscarinic receptors in these areas produces…”
Get more information

Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study by Dudley, J, Rauw, G, Hawes, E M, Keegan, D L, Midha, K K

“…Five schizophrenic patients (diagnosed using Research Diagnostic Criteria) under treatment with intramuscular fluphenazine decanoate or oral fluphenazine…”
Get more information

Chronic urticaria: clinical psychophysiological and therapeutic aspects by Keegan, D L

Get more information